Intraductal papillary neoplasm of the bile duct
A type of tumor in the bile duct
Intraductal papillary neoplasm of the bile duct (IPNB) is a type of tumor that occurs within the bile ducts. It is characterized by the growth of papillary structures within the bile duct lumen and is considered a precursor to cholangiocarcinoma, a type of bile duct cancer.
Pathophysiology[edit | edit source]
IPNBs are thought to arise from the epithelial cells lining the bile ducts. These neoplasms exhibit a papillary growth pattern, which means they form finger-like projections. The papillary structures can cause obstruction of the bile duct, leading to jaundice and other symptoms. Histologically, IPNBs can show varying degrees of dysplasia, ranging from low-grade to high-grade, and may progress to invasive carcinoma.
Clinical Presentation[edit | edit source]
Patients with IPNB may present with symptoms such as abdominal pain, jaundice, and pruritus. These symptoms are often due to bile duct obstruction. In some cases, patients may be asymptomatic, and the neoplasm is discovered incidentally during imaging studies for other conditions.
Diagnosis[edit | edit source]
The diagnosis of IPNB is typically made through a combination of imaging studies and histological examination. Imaging techniques such as magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP) are used to visualize the bile ducts and identify any intraductal lesions. A biopsy may be performed to obtain tissue samples for histological analysis.
Treatment[edit | edit source]
The primary treatment for IPNB is surgical resection. The extent of surgery depends on the location and size of the neoplasm. In some cases, a hepatectomy or pancreaticoduodenectomy (Whipple procedure) may be necessary. The goal of surgery is to remove the neoplasm completely to prevent progression to invasive cancer.
Prognosis[edit | edit source]
The prognosis for patients with IPNB depends on several factors, including the degree of dysplasia and the presence of invasive carcinoma. Patients with low-grade dysplasia have a better prognosis compared to those with high-grade dysplasia or invasive cancer. Early detection and complete surgical resection are associated with improved outcomes.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
